Trade TBPH anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Theravance Biopharma, Inc. (TBPH) is trading at US$17.04, down 0.03% today as of Aug 28, 12:40 EDT. The company has a market capitalisation of US$883.14M. Over the past 52 weeks, TBPH has traded between US$13.08 and US$21.03. On Syfe you can trade TBPH with $0 commission and add it to your watchlist.
| Previous close | US$17.04 |
|---|---|
| Market cap | US$883.14M |
| P/E ratio | 7.69 |
| 52-week range | US$13.08 – US$21.03 |
| Volume | 487.33K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of human therapeutics. It operates through the following geographical segments: US and Europe. The company was founded in July 2013 and is headquartered in South San Francisco, CA.
Year: 2014
Theravance Biopharma Insider Sold Shares Worth $5,791,555, According to a Recent SEC Filing
Jul 2, 8:23 AM · MT Newswires
Sector Update: Healthcare Stocks Higher Late Afternoon
Jun 29, 7:59 PM · MT Newswires
Theravance Biopharma, Inc. (TBPH) stock is trading at US$17.04, -0.03% from the previous close of US$17.04.
The market cap for Theravance Biopharma, Inc. (TBPH) stock is approximately US$883.14M.
The price-to-earnings ratio for Theravance Biopharma, Inc. (TBPH) is 7.69, based on the latest reported earnings.
The 52-week high for Theravance Biopharma, Inc. (TBPH) stock is US$21.03.
The 52-week low for Theravance Biopharma, Inc. (TBPH) stock is US$13.08.
Theravance Biopharma, Inc. (TBPH) does not currently pay a dividend.
Stay on top of TBPH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
